Integral Diagnostics Akcija

Integral Diagnostics EBITDA

Vrijednost EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od Integral Diagnostics (IDX.AX) na dan 14. авг 2026. je 114,83 М AUD. Prethodne godine, EBITDA (Заработак пре камата, пореза, амортизације и отписивања) je bio 89,03 М AUD — promjena od 28,97% (viši).

EBITDA

114,83 МAUD

YoY

28,97%

Zadnja ažuriranja:

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od Integral Diagnostics je 2026 114,83 М AUD. EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od Integral Diagnostics je bio 2025 89,03 М AUD. Pad je time 28,97% viši u odnosu na prethodnu godinu.
Access this data via the Eulerpool API

Integral Diagnostics Анализа акција

Šta radi Integral Diagnostics? Integral Diagnostics Ltd is an Australian company that has been providing medical imaging services for over 25 years. The company was founded in 1994 by Dr. Ian Kadish and a team of radiologists in Perth, Western Australia, offering radiology services to local clinics and hospitals. Over the years, Integral Diagnostics has expanded its services to provide imaging services nationwide. The business model of Integral Diagnostics is to deliver medical imaging to enable doctors and their patients to have a fast and accurate diagnosis. The company offers imaging services for a variety of medical specialties, including radiology, cardiology, obstetrics and gynecology, and neurology. They operate over 49 locations in Australia, many of which are in rural areas where access to medical care may be limited. Integral Diagnostics offers a wide range of products based on medical imaging. These include X-rays, mammography, ultrasound, CT scans, MRI scans, PET scans, and bone density scans. The company takes pride in being one of the few Australian medical imaging companies to offer a complete range of imaging services. Their services are conducted by qualified radiologists specialized in interpreting medical images. Integral Diagnostics also operates clinics for performing diagnostic and therapeutic procedures such as biopsies, drainages, and injections. These procedures are carried out by highly qualified radiologists to provide patients with faster and more accurate diagnoses. Integral Diagnostics is committed to quality assurance and has a comprehensive quality management system that is annually reviewed by independent auditors. The company is accredited by both the Australian Medical Association and the Australian National Accreditation Scheme (NATA). These accreditations recognize the high standards that Integral Diagnostics sets for delivering medical imaging services. One of Integral Diagnostics' recent activities is their use of artificial intelligence (AI) in image interpretation. The company has partnered with MaxQ AI, a leading provider of AI solutions for medical imaging. Through this partnership, Integral Diagnostics doctors can utilize the latest AI tools to improve their patients' diagnoses. Integral Diagnostics is a strong advocate for social justice and is dedicated to supporting disadvantaged communities in Australia. The company has partnered with nonprofit organizations such as the National Breast Cancer Foundation, The Smith Family, and the Friendship Foundation. Overall, Integral Diagnostics has undergone impressive growth over the past 25 years and is now a leading Australian medical imaging company. With a wide range of imaging services and a strong focus on quality and social responsibility, the company is well-positioned to continue its success in the future. Integral Diagnostics je jedna od najpopularnijih kompanija na Eulerpool.

Često postavljena pitanja o akciji Integral Diagnostics

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) kompanije Integral Diagnostics iznosi 114,83 М AUD u 2026. godini.

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od Integral Diagnostics se promijenio sa 89,03 М AUD na 114,83 М AUD, što predstavlja promjenu od 28,97%. Vrijednost je viši nego prethodne godine.

Na Eulerpool-u možete pronaći potpuni historijski razvoj EBITDA (Заработак пре камата, пореза, амортизације и отписивања) Integral Diagnostics od 2006. — sa godišnjim vrijednostima, grafikonima i detaljnom analizom.

EBITDA мери оперативну перформансу пре утицаја финансијске структуре, окружења пореза и не-готовинских отписивања.

EBITDA = EBIT + Амортизација и отписивање

EBITDA (Заработак пре камата, пореза, амортизације и отписивања)'s AUD je ključan faktor za investitore. Promene u ovoj metrici mogu signalizirati poboljšane ili pogoršane fundamentalne faktore, direktno utiču na cenu akcije. Na Eulopoolu, možete pratiti EBITDA (Заработак пре камата, пореза, амортизације и отписивања)'s Integral Diagnostics istorijski i u realnom vremenu.

Access this data via the Eulerpool API

Извештај о добити и губитку — Integral Diagnostics

Sve ključne metrike — Integral Diagnostics

Раст